Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | CASP3 | P42574 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | ATM | Q13315 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.33 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.33 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24300092 | 0.81 | — | — | |
| SCHEMBL20885124 | 0.77 | MAPK1 (0.50) | NPC1LMNAMAPK1CASP3RAB9A | |
| SCHEMBL14435170 | 0.76 | NPC1 (0.39) | NPC1LMNAMAPK1CASP3RAB9A | |
| SCHEMBL13196161 | 0.72 | MEN1 (0.31) | — | |
| SCHEMBL14515088 | 0.72 | PDK2 (0.41) | — | |
| SCHEMBL13553389 | 0.72 | KIF11 (0.37) | NPC1LMNAMAPK1CASP3RAB9A | |
| SCHEMBL25444705 | 0.72 | PDK2 (0.41) | — | |
| SCHEMBL17248124 | 0.72 | KDM4E (0.31) | NPC1RAB9ASMN1; SMN2 | |
| SCHEMBL12796175 | 0.72 | CNR1 (0.31) | — | |
| SCHEMBL26056450 | 0.71 | NPC1 (0.36) | NPC1LMNAMAPK1CASP3RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190002488-A1 | LIGHT-EMITTING COMPOUND | CAMBRIDGE DISPLAY TECHNOLOGY LIMITED (GB) | 2019-01-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190002488-A1 | LIGHT-EMITTING COMPOUND | AR, ARL1, IK | NPC1 3796/4885LMNA 1291/4885MAPK1 3070/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.